Cytosorbents (CTSO) Gross Profit (QoQ) (2012 - 2026)
Cytosorbents (CTSO) Gross Profit (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Cytosorbents | 23.46 Mn | 18.66 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.91% |
| Dec 31, 2025 | 2.07% |
| Sep 30, 2025 | -2.17% |
| Jun 30, 2025 | 9.78% |
| Mar 31, 2025 | -0.77% |
| Dec 31, 2024 | 19.01% |
| Sep 30, 2024 | -19.18% |
| Jun 30, 2024 | -5.39% |
| Mar 31, 2024 | 29.42% |
| Dec 31, 2023 | -5.27% |
| Sep 30, 2023 | -6.84% |
| Jun 30, 2023 | 10.32% |
| Mar 31, 2023 | -5.24% |
| Dec 31, 2022 | 59.15% |
| Sep 30, 2022 | -26.85% |
| Jun 30, 2022 | -22.90% |
| Mar 31, 2022 | -16.26% |
| Dec 31, 2021 | 4.96% |
| Sep 30, 2021 | -21.65% |
| Jun 30, 2021 | 18.69% |